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Summary Background: Transbronchial needle aspiration (TBNA) has been shown to be
useful not only for the diagnosis and staging of lung cancer, its most widely studied
indication, but also for many of other clinical indications. Despite this, it remains
largely underutilized, mainly because of concerns with poor yield, safety, lack of
experience of the bronchoscopist, and lack of cytopathological support.
Objective: To study the clinical utility and yield of TBNA as an adjunct to other
conventional procedures in diagnostic bronchoscopy at a centre that was relatively
inexperienced with this technique, but where there was availability of rapid on-site
evaluation (ROSE). Most of the major indications for TBNA in both malignant as well as
benign disease were included.
Setting: University Teaching Hospital na.ıve to the procedure.
Patient and methods: Forty-five consecutive patients who underwent TBNA as part
of diagnostic bronchoscopy during a 2-year study period.
Results: TBNA gave a yield of 65% for evaluation of mediastinal disease, both benign
and malignant. The overall diagnostic utility for all indications was 71% and there
were no complications.
Conclusions: We conclude that TBNA is a useful and safe adjunct to diagnostic
bronchoscopy in routine clinical practice. It has a satisfactory yield even with an
inexperienced team, if used with ROSE.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Transbronchial needle aspiration (TBNA) is a tech-
nique usually performed with a flexible broncho-
scope, that provides cytological or histological
sampling of mediastinal lesions that lie adjacent
to the tracheobronchial tree and peribronchial,
submucosal, endobronchial, as well as peripheral
lesions.
The transbronchial puncture of mediastinal
lymph nodes via a rigid bronchoscope was first
described in 1949 by Argentine surgeon Eduardo
Schieppati.1 In a later publication he described his
results with this technique in a series of patients
the majority of whom had suspected bronchogenic
or esophageal carcinoma, and concluded that:
This method is free of great risks and, in my opinion,
its application could be extended to other diseases,
i.e., mediastinal tumors, Hodgkin’s disease, sarcoido-
sis and lymphogranuloma. This method permits the
exploration of important areas which are difficult to
approach by any other means.2
In the early 1980s, Wang and Terry then introduced
an apparatus needle for performing needle
aspiration by using a flexible bronchoscope and this
led to the birth of modern TBNA. True to the words
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of Schieppati written more than 30 years ago, TBNA
is at present gaining increasing popularity, due to
its expanding clinical applications.
Despite the many indications for TBNA, it has
remained a largely underutilized technique.3 The
possible reasons for this include concern with its
safety (complications and fear of damaging the
bronchoscope), lack of familiarity with the equip-
ment and needles, lack of expertise and training,
lack of adequate cytopathological support, and low
yield or unpredictable results. Different operators
with varying degrees of expertise may obtain a
wide range of sensitivities with TBNA.4 One of the
factors affecting the yield is that there is a learning
curve in this technique. Haponik et al. demon-
strated the effect of education and experience in
improving the yield from 21.4% to 47.6% over a 3-
year study period.5 Rong and Cui reported a yield of
20% during their initial experience with TBNA. This
immediately increased to 60% when the authors
chose to use CT guidance to ensure needle
placement on-site.6 Subsequent to that, the use-
fulness of real-time guidance with CT fluoroscopy
to improve yield has also been studied.7,8
Our aim was to study the diagnostic utility and
yield of TBNA in a centre that was relatively na.ıve
to the procedure, as an adjunct to routine clinical
practice.
Materials and methods
Setting: A university hospital where TBNA had been
only attempted sporadically in the past. We
prospectively collected data on all TBNAs per-
formed at the National University Hospital, Singa-
pore, between August 1, 2000 and July 31, 2002.
They were all performed by a pulmonologist who
had limited experience with the technique, having
done a total of 10 supervised TBNAs during his
training at another centre, and one unsupervised
TBNA prior to the start of the study, and 2 fellows-
in-training who were taught the technique for the
first time by the aforementioned. The decision to
perform the TBNAs was either made on review of a
prebronchoscopy CT chest that showed mediastinal
disease or a peribronchial lesion that was deemed
suitable for TBNA, or decided upon at the time of
bronchoscopy whereby either one of the 3 bronch-
oscopist in the study felt that it would be useful,
e.g. for submucosal and endobronchial disease.
Technique: Bronchoscopy was performed using
standard flexible videobronchoscopes (Olympus
Optical Co. Ltd., Japan). During the procedure,
specimens were obtained by TBNA, with or without
other conventional diagnostic procedures such as
bronchoalveolar lavage, bronchial brushings, endo-
bronchial forceps biopsy, and transbronchial lung
biopsy. There was an attempt to perform the TBNA
before other procedures to avoid endobronchial
contamination. However, there were occasions
when TBNA was done after other procedures were
performed as a second line procedure, for example
when endobronchial forceps biopsy caused exces-
sive bleeding or failed to yield adequate tissue in
cases of submucosal lesions.
All TBNA specimens were obtained with a Wang/
Mill-rose MW 222 cytology needle (Bard Endoscopic
Technologies, Masachussets, USA). The techniques
employed for wall penetration were the jabbing
and hub against wall method.9 Aspirated specimens
were blown onto a slide using the ‘‘smear techni-
que’’,10 air-dried for Diff-Quik staining and imme-
diately reviewed by an experienced cytologist at
the bronchoscopy suite (rapid on-site evaluation or
ROSE). The remaining samples were fixed with
ethanol for Papicoloau staining and the excess
material flushed into a container with normal saline
for further processing for cell-block.
Results
TBNA was performed at 49 sites in 45 consecutive
patients, all of whom were undergoing diagnostic
bronchoscopy during the 2-year study period. In 42
patients, bronchoscopy was planned after review of
the chest CT Scans by the team.11 Three patients
did not have a CT chest at the point of broncho-
scopy and TBNA was done for suspected submucosal
disease in all 3 cases. The total number of passes
taken for each site was between 1 and 8, and this
included passes taken by the fellows-in-training,
with a mean of 3.1 passes per site. If only 1 pass
was made, this was because ROSE was positive on
the first pass. Thirty-five specimens yielded a
diagnosis on-site with ROSE. Three adequate speci-
mens were positive only after further processing
and the remaining 11 specimens were reported as
inadequate.
The majority of TBNA were done for evaluating
mediastinal lesions on chest CTs (n ¼ 26). The other
indications included peribronchial masses on chest
CT (n ¼ 7), suspected submucosal disease (n ¼ 9),
and endobronchial tumors (n ¼ 7). (see Table 1).
Seventeen of the 26 TBNAs performed for
evaluating mediastinal lesions were positive, giving
a yield of 65.4% for this indication. The disease was
due to malignancy in 23 cases; 2 showed granulo-
matous inflammation from sarcoidosis and one
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showed acid fast bacilli from tuberculosis. The
majority of TBNA performed for mediastinal lesions
were at the subcarinal site (n ¼ 20); 4 were right
paratracheal, and 2 left paratracheal (see Table 2).
Of the 26 patients who had TBNA for mediastinal
disease, 4 had additional TBNAs done at a different
site, one for suspected submucosal disease, and
three for an endobronchial lesion.
Seven patients had a peribronchial mass that was
deemed suitable for TBNA on reviewing the
prebronchoscopy chest CT. Five were positive for
malignancy, and one showed necrosis with epithe-
liod cells suggestive of tuberculosis. Eight of the 9
TBNAs that were done for suspected submucosal
disease were positive for malignancy. All 7 TBNAs of
endobonchial lesions were positive: one for recur-
rent endobronchial Wilms tumor, three for non-
small cell carcinoma and 3 for small cell carcinoma
(see Table 2).
Overall, TBNA was positive in 35 of 49 sites giving
an overall yield of 71.4%. No complications related
to the TBNA were documented. Neither was there
any damage to the bronchoscopes.
Discussion
The aim of the study was to determine the utility
and yield of TBNA as an adjunct to diagnostic
bronchoscopy in routine clinical practice, in rela-
tively inexperienced hands. Whilst de Castro et al.12
have actually suggested that at least 50 TBNA
procedures are necessary to become proficient in
the technique, the bronchoscopist involved in this
study was actually performing his 12th TBNA and
second unsupervised TBNA at the start of study.
Despite relative inexperience, it was a safe proce-
dure with none of the documented complications.13
The well studied and predominant utility of
TBNA has been in the staging of bronchogenic
carcinoma.14–17 However, it has also been used to
evaluate mediastinal lymphadenopathy from non-
malignant conditions such as Sarcoidosis18–21 and
mycobacterial infection.22,23 The diagnostic useful-
ness of modern TBNA has been extended beyond
evaluation of mediastinal lymphadenopathy and
non-surgical staging of lung cancer, to include
sampling of peripheral, submucosal and peribron-
chial tumors.24–29 Basically the technique can be
used to access lesions that are beyond the
tracheobronchial tree such as mediastinal lymph
nodes and masses, peribronchial lesions, and
lesions within the submucosa. However, these
lesions should be within reach of the 13mm long
needle and permit aspiration via the endoluminal
approach.
We did not examine its utility for a specific
indication such as the staging of bronchogenic
carcinoma. Instead, we looked at its use when
appropriate for known clinical indications in the
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Table 1 Indications for TBNA and results.
Indication n Diagnostic Result Yield (%)
Evaluation of mediastinal lymphadenopathy 26 17 See Table 2 65.5
Peribronchial mass without endobronchial lesion 7 1 Necrotizing granuloma 57.1
3 Non-small cell lung cancer
Suspected submucosal disease 9 7 Non-small cell lung cancer 88.9
1 Small cell lung cancer
Endobronchial tumor 7 1 Metastatic wilms 100
3 Non-small cell lung cancer
3 Small cell lung cancer
Table 2 Diagnostic TBNA for evaluation of mediastinal masses and lymphadenopathy.
Result Site of TBNA n %
Non-small cell lung cancer Subcarinal 15 80.8
Right paratracheal 4 Total¼ 21
Left paratracheal 2
Small cell lung cancer Subcarinal 2 7.7
Non-caseating granuloma Subcarinal 2 7.7
Acid fast bacilli, necrosis Subcarinal 1 3.8
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setting of diagnostic bronchoscopy in routine
clinical practice. Thus it was used as an addition
to the routine conventional diagnostic procedures
available to the bronchoscopist in both benign as
well as malignant diseases. The indications in-
cluded all the major indications listed above with
the exception of its utility in peripheral mass
lesions whereby we felt that the procedure of
choice would still be a guided transthoracic needle
aspiration.
Though the numbers in this study are relatively
small, we wanted to describe our initial experience
with this technique. At our teaching institution,
TBNA had only been performed sporadically prior
to the study by another pulmonologist who did
not employ ROSE and subsequently abandoned
the technique, due to concerns with poor yield.
The pulmonologist involved in this study also did
not utilize ROSE during his first 10 supervised TBNAs
at another institution, and shared the same
concern, and therefore decided to embark on this
study.
We tried to improve the yield by utilizing ROSE
since we revisited this technique. ROSE proved to
be very useful in determine the adequacy of the
sample and therefore limiting the number of passes
taken, and it has also been shown to increase the
yield.30,31 In addition, most patients had tomo-
graphic evaluation prior to a planned TBNA.11
With the above measures, a satisfactory yield
was obtained even without on-site CT guidance. We
conclude that despite relatively inexperienced
hands, TBNA remained a useful adjunct in routine
diagnostic bronchoscopy. It was safe even with our
limited experience, and relatively easy to perform.
In our opinion, an important factor in contribut-
ing to the satisfactory yield despite inexperience
since revisiting this largely underutilized technique
was ROSE.
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